Abstract Glucagon-like peptide-1 (GLP-1), an incretin hormone, is released from intestinal L-
cells in response to nutrients. GLP-1 lowers blood glucose levels by stimulating insulin …

Type 1 diabetes mellitus (T1D) is a chronic, multifactorial autoimmune disease that involves
the progressive destruction of pancreatic β-cells, ultimately resulting in the loss of insulin …

This review will detail the current status of islet xenotransplantation as a potential treatment
for type I diabetes mellitus, focusing on recent advances in porcine xenogeneic islet …

Due to current improvements in techniques for islet isolation and transplantation and
protocols for immunosuppressants, islet transplantation has become an effective treatment …

Encapsulation of pancreatic islets has been proposed and investigated for over three
decades to improve islet transplantation outcomes and to eliminate the side effects of …

The bioartificial pancreas (BAP) represents a viable solution for the treatment of type 1
diabetes (T1D). By encapsulating pancreatic cells in a semipermeable membrane to allow …

Urine-derived stem cells (USCs) are isolated from voided urine and display high proliferative
activity and multiple differentiation potentials. The applicability of USCs in the treatment of …

Diabetes can be managed by careful monitoring of blood glucose and timely delivery of
exogenous insulin. However, even with fastidious compliance, people with diabetes can …

Diabetic wound management is a serious health care challenge due to higher rates of
relapse, expensive treatment approaches, and poor healing outcomes. Among cell-based …

Type 1 diabetes (T1D) can be managed by transplanting either the whole pancreas or
isolated pancreatic islets. However, cadaveric pancreas is scarcely available for clinical use …